LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Cash and short-term investments (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $9.0B | +152.4% | 14.6% | 5.0% |
| Cash and short-term investments (Q2 2026) | $9.0B |
|---|---|
| YoY | +152.4% |
| 5-year CAGR | 14.6% |
| 10-year CAGR | 5.0% |
Cash and short-term investments
| Period | Cash | YoY |
|---|---|---|
| 2025 | $7.3B | +112.3% |
| 2024 | $3.4B | +16.9% |
| 2023 | $2.9B | +32.4% |
| 2022 | $2.2B | −43.4% |
| 2021 | $3.9B | +6.2% |
| 2020 | $3.7B | +51.0% |
| 2019 | $2.4B | −67.1% |
| 2018 | $7.4B | −7.8% |
| 2017 | $8.0B | +33.0% |
| 2016 | $6.0B | +35.6% |
| 2015 | $4.5B | −7.8% |
| 2014 | $4.8B | −10.6% |
| 2013 | $5.4B | −5.0% |
| 2012 | $5.7B | −17.6% |
| 2011 | $6.9B | +2.5% |
| 2010 | $6.7B | +49.6% |
| 2009 | $4.5B | −24.1% |
| 2008 | $5.9B | +84.0% |
| 2007 | $3.2B | — |